Shenzhen Weiguang Biological Products Co., Ltd.

SZSE:002880.SZ

33.35 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q22015 Q1
Revenue 331.199294.129226.302313.071278.265248.649208.518256.498179.58794.063137.783290.678280.969197.141138.648296.905200.103218.09189.466287.449173.49191.64168.889219.44169.392168.069131.049182.482128.764163.652148.492132.852146.646148.868137.77137.362137.362
Cost of Revenue 193.215180.054128.362195.346155.465142.971121.477183.515114.98649.90478.62170.904165.772117.79582.051185.845121.982131.203129.188169.609102.005122.893111.626144.19895.80595.62178.704108.76963.46390.65484.28967.50374.7556.26699.3275.18875.188
Gross Profit 137.984114.07497.94117.725122.8105.67887.04172.98364.60244.1659.163119.774115.19679.34556.596111.0678.12186.88760.278117.8471.48568.74857.26375.24273.58772.44952.34473.71365.30272.99864.20265.3571.89792.60138.45162.17362.173
Gross Profit Ratio 0.4170.3880.4330.3760.4410.4250.4170.2850.360.4690.4290.4120.410.4020.4080.3740.390.3980.3180.410.4120.3590.3390.3430.4340.4310.3990.4040.5070.4460.4320.4920.490.6220.2790.4530.453
Reseach & Development Expenses 17.2386.49312.22413.18131.6527.96410.827.59113.8553.9610.4612.93514.57210.5689.51116.44710.45812.5145.67717.5826.7285.23510.624.4519.62114.2135.04632.7997.211.254024.774012.09404.5774.577
General & Administrative Expenses 51.818-8.96319.969-32.22846.047-6.03716.899-27.1537.872-8.03215.327-25.84436.709-3.19213.497-15.71513.050.65213.303-11.36711.582-2.7312.322-16.41911.92-6.80316.163-31.93318.572-7.97215.809-31.96317.04531.173013.76613.766
Selling & Marketing Expenses 12.2117.4495.21915.898.17312.4374.38410.7737.1664.9754.346.1266.9914.5776.0913.9274.526.8624.3827.866.8423.4445.8744.7399.0385.774.4653.0495.5653.5822.1575.3292.2755.2402.6692.669
SG&A 64.0327.90225.188-16.33754.226.421.284-16.37745.038-3.05719.667-19.71743.6991.38419.588-11.78817.577.51417.684-3.50718.4240.71318.196-11.6820.958-1.03420.628-28.88424.138-4.39117.965-26.63419.3237.035017.11117.111
Other Expenses -35.631-0.422-0.039-0.472-1.2051.557-1.21146.522-23.58820.324-0.658-0.2634.356-4.512-0.147-7.6050.059-1.479-1.478-1.6180.098-0.271-0.3150.323-0.1991.8210.06510.787-0.0681.6541.4928.7590.028-104.527-99.3200
Operating Expenses 45.63734.39537.61752.56358.61842.02930.89237.73635.30621.22829.46937.18839.37529.21228.09638.36427.31135.93422.72341.69324.68418.85928.08818.09828.4121.35420.17622.43424.1621.22919.25531.32418.384-104.527-99.3216.33516.335
Operating Income 85.4879.6855.3868.67457.00364.43957.19253.59128.10325.70930.76483.82274.9750.9432.00976.851.08653.65939.09968.8346.92450.84232.54855.72646.12551.44328.70652.32136.85946.70939.58731.12148.51544.34138.45144.38744.387
Operating Income Ratio 0.2580.2710.2450.2190.2050.2590.2740.2090.1560.2730.2230.2880.2670.2580.2310.2590.2550.2460.2060.2390.270.2650.1930.2540.2720.3060.2190.2870.2860.2850.2670.2340.3310.2980.2790.3230.323
Total Other Income Expenses Net -0.162-3.685-0.039-0.4720.377-0.025-1.734-0.481-0.2030.021-0.187-0.263-0.9290.7283.3613.6770.3352.9490.067-7.9530.2210.9563.058-2.6220.7491.509-3.3963.274-4.35100.139-107.4158.44-4.9794.06-97.891-4.533-4.533
Income Before Tax 85.31875.99555.34168.20257.3864.41455.45853.1127.925.73130.57783.55974.89350.86131.86276.37351.14553.90237.62168.19447.02250.84532.23354.52245.92652.60328.77254.55336.79148.36341.07742.46548.54248.5939.8839.85339.853
Income Before Tax Ratio 0.2580.2580.2450.2180.2060.2590.2660.2070.1550.2740.2220.2870.2670.2580.230.2570.2560.2470.1990.2370.2710.2650.1910.2480.2710.3130.220.2990.2860.2960.2770.320.3310.3260.2890.290.29
Income Tax Expense 12.51913.0628.5472.0066.929.1529.8324.72224.1035.37215.7967.367.985.0467.1167.8958.2846.166.4028.1957.2915.2535.9567.028.1824.0286.7615.6157.2646.3955.0177.75397.48-93.5096.0426.042
Net Income 72.83963.0346.83267.4150.21555.2945.73644.67425.88321.55325.33367.76467.71342.97426.98669.42743.47145.81931.68261.94138.87143.55326.9848.56638.90644.42124.74447.79231.17641.134.68237.44840.78940.9234.0733.81133.811
Net Income Ratio 0.220.2140.2070.2150.180.2220.2190.1740.1440.2290.1840.2330.2410.2180.1950.2340.2170.210.1670.2150.2240.2270.160.2210.230.2640.1890.2620.2420.2510.2340.2820.2780.2750.2470.2460.246
EPS 0.320.280.210.30.220.240.20.20.110.0950.110.30.30.190.170.310.190.20.210.270.260.190.120.210.170.20.110.210.140.340.20.220.240.240.20.20.2
EPS Diluted 0.320.280.210.30.220.240.20.20.110.0950.110.30.30.190.170.310.190.20.210.270.260.190.120.210.170.20.110.210.140.340.20.220.240.240.20.20.2
EBITDA 90.815107.93360.42870.33965.1864.03954.77939.79830.24823.89530.26483.54877.93651.45632.15675.27852.90453.80336.6575.8547.51950.1329.04456.26745.53750.69135.12554.25343.124-49.698148.49244.48754.119-45.47137.7754.40554.405
EBITDA Ratio 0.2740.3670.2670.2250.2340.2580.2630.1550.1680.2540.220.2870.2770.2610.2320.2540.2640.2470.1930.2640.2740.2620.1720.2560.2690.3020.2680.2970.335-0.30410.3350.369-0.30510.3960.396